Thermopylae Holdings Ltd. - 13 May 2022 Form 4 Insider Report for AbCellera Biologics Inc. (ABCL)

Role: 10%+ Owner
Signature: /s/ Tryn Stimart, attorney-in-fact
Issuer symbol: ABCL
Transactions as of: 13 May 2022
Net transactions value: +$2,176,530
Form type: 4
Filing time: 17 May 2022, 15:04:45 UTC
Previous filing: 16 May 2022
Next filing: 08 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ABCL	Common Shares	Purchase	$2,176,530	+300,000	+0.54%	$7.26	55,515,758	13 May 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted-average price. These shares were acquired in multiple transactions at prices ranging from $6.88 to $7.38. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.

Content

The price reported in Column 4 is a weighted-average price. These shares were acquired in multiple transactions at prices ranging from $6.88 to $7.38. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.